# Elicio Therapeutics

Type: Company (ELTX)

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/elicio-therapeutics
Canonical HTML page: https://getbiobrief.com/entity/elicio-therapeutics

## Recent coverage (1 stories)

### AMT-130, NEO212 Progress: 4 Biotech Stocks Jump on Gene Therapy, M&A News
2026-06-19 00:09:11 · Sentiment: Positive · Impact: 6/10 · Sources: 2

uniQure’s AMT-130 update validates its gene therapy platform, while NTHI’s NEO212 advancement and an acquisition deal spotlight a busy week for biotech pipelines and dealmaking.
Full story: https://getbiobrief.com/story/amt130-neo212-biotech-surge

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.